Adiponectin Receptor Signaling on Dendritic Cells Blunts Antitumor Immunity
- 14 October 2014
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 74 (20) , 5711-5722
Abstract
Immune escape is a fundamental trait of cancer. Dendritic cells (DC) that interact with T cells represent a crucial site for the development of tolerance to tumor antigens, but there remains incomplete knowledge about how DC-tolerizing signals evolve during tumorigenesis. In this study, we show that DCs isolated from patients with metastatic or locally advanced breast cancer express high levels of the adiponectin receptors AdipoR1 and AdipoR2, which are sufficient to blunt antitumor immunity. Mechanistic investigations of ligand–receptor interactions on DCs revealed novel signaling pathways for each receptor. AdipoR1 stimulated IL10 production by activating the AMPK and MAPKp38 pathways, whereas AdipoR2 modified inflammatory processes by activating the COX-2 and PPARγ pathways. Stimulation of these pathways was sufficient to block activation of NF-κB in DC, thereby attenuating their ability to stimulate antigen-specific T-cell responses. Together, our findings reveal novel insights into how DC-tolerizing signals evolve in cancer to promote immune escape. Furthermore, by defining a critical role for adiponectin signaling in this process, our work suggests new and broadly applicable strategies for immunometabolic therapy in patients with cancer. Cancer Res; 74(20); 5711–22. ©2014 AACR.Keywords
All Related Versions
This publication has 46 references indexed in Scilit:
- Matrix Metalloproteinase-9 Regulates Tumor Cell Invasion through Cleavage of Protease Nexin-1Cancer Research, 2010
- Dendritic Cell (DC)-Specific Targeting Reveals Stat3 as a Negative Regulator of DC FunctionThe Journal of Immunology, 2010
- Adiponectin Inhibits Pro-inflammatory Signaling in Human Macrophages Independent of Interleukin-10Journal of Biological Chemistry, 2009
- Development of a Wilms' tumor antigen-specific T-cell receptor for clinical trials: engineered patient's T cells can eliminate autologous leukemia blasts in NOD/SCID miceHaematologica, 2009
- Adiponectin deficiency does not affect development and progression of spontaneous colitis in IL-10 knockout miceAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2009
- Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in miceJournal of Clinical Investigation, 2008
- Adiponectin differentially affects gene expression in human mammary epithelial and breast cancer cellsBritish Journal of Cancer, 2008
- Adiponectin suppresses colorectal carcinogenesis under the high-fat diet conditionGut, 2008
- Adiponectin modulates inflammatory reactions via calreticulin receptor–dependent clearance of early apoptotic bodiesJournal of Clinical Investigation, 2007
- Cloning of adiponectin receptors that mediate antidiabetic metabolic effectsNature, 2003